Open Label Extension in Adults With Binge Eating Disorder (BED)
Completed · Phase 3
Conditions studied: Binge Eating Disorder
In brief
To evaluate the safety and tolerability of SPD489 administered as a daily morning dose (50 or 70mg) in the treatment of moderate to severe binge eating disorder (BED) in adults
Key facts
- Study ID
- NCT01657019
- Run by
- Shire
- People needed
- 604
- Starts
- 2012-08-21
- Expected to finish
- 2014-10-21
- Last updated by the study team
- 2021-06-09
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Completion of an antecedent SPD489 BED Double-blind Study
- Subject meets the following Diagnostic and Statistical Manual of Mental Disorders Fourth Edition - Text Revision (DSM-IV-TR) criteria for a diagnosis of BED
- Subject has a body mass index (BMI) of > or =18 and < or =45
You may not qualify if…
- Subject has concurrent symptoms of bulimia nervosa or anorexia nervosa.
- Subject is considered a suicide risk or risk to harm others
Where it is running
- Radiant Research — Tucson, Arizona, United States
- Clinical Study Centers, LLC — Little Rock, Arkansas, United States
- Southwestern Research, Inc. — Beverly Hills, California, United States
- TRIMED Clinical Trials — Corona, California, United States
- Pharmacology Research Institute — Encino, California, United States
- Scripps Clinical Research Services — La Jolla, California, United States
- Pharmacology Research Institute — Los Alamitos, California, United States
- Pharmacology Research Institute — Newport Beach, California, United States
- Pacific Research Partners, LLC — Oakland, California, United States
- Excell Research, Inc — Oceanside, California, United States
- PCSD - Feighner Research — San Diego, California, United States
- Western Affiliated Research Institute, Inc — Denver, Colorado, United States
- Radiant Research, Inc — Denver, Colorado, United States
- Florida Clinical Research — Bradenton, Florida, United States
- Gulfcoast Clinical Research — Fort Myers, Florida, United States
- Clinical Neuroscience Solutions, Inc — Jacksonville, Florida, United States
- Fidelity Clinical Research, Inc — Lauderhill, Florida, United States
- Compass Research, LLC — Leesburg, Florida, United States
- Florida Clinical Research Center, LLC — Maitland, Florida, United States
- Scientific Clinical Research, Inc — North Miami, Florida, United States
- Clinical Neuroscience Solutions, Inc — Orlando, Florida, United States
- Miami Research Associates — South Miami, Florida, United States
- Atlanta Institute of Medicine and Research — Atlanta, Georgia, United States
- Neurotrials Research, Inc — Atlanta, Georgia, United States
- Birmingham Research Group — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.